Day 1

Session I: Diagnosis, Biology and MRD

Moderators: Dr. Javid Gaziev, Dr. Ahmed Al Sabbagh, Dr. Walid Al Wali

TIME

TOPICS

SPEAKER

7.30am - 12pm

Registration

8am - 8.30am

Welcome Remarks and Opening Ceremony

• Dr. Mohamed Salem
• Dr. Al Hareth Al Khater
• Dr. Javid Gaziev
• Dr. Honar Cherif
• Dr. Ussama Al Homsi
• Dr. Noora Al Hammadi

8.30am - 8.50am

Epidemiology of ALL in Qatar in Adults patients

Dr. Halima El Omri
Associate Professor of Hematology
Sr. Consultant physician
Hematology - BMT Dept.
NCCCR - HMC
Qatar

8.50am - 9.10am

2022 Diagnostic and Biology Updates in ALL

Dr. Sayed Hassan Rizvi
Sr. Consultant - Hematopathology
DLMP - HMC
Doha, Qatar

9.10am - 9.30am

Genetic subtypes of ALL

Dr. Susanna El Akiki
Genomic and Molecular Lab
DLMP - HMC
Qatar

9.30am - 9.50am

FCM of ALL and focus on mixed phenotype ALL

Dr. Sandra Sapia
Assistant professor of Pathology and Laboratory Medicine
Weill Cornell Medicine
Qatar

9:30am - 10.10 am

NGS for diagnosis and monitoring of lymphoid malignancies.

Dr. Marianna Graham
Head of the Cytogenetics and Molecular
Hematology Department
Barts Health NHS
London-UK

10.10am - 10.30am

Clinical application of MRD in ALL

Prof. Ali Bazarbachi
Professor of Medicine - Hematology
American University of Beirut
Lebanon

10.30am to 10.45am (15minutes)

Coffee Break

Moderators: Dr. Naeema Al Mulla, Dr. Sara Diola
Sidra Medicine

10.45am - 11.05am

Mechanism of treatment resistance in pediatric T -

ALL

Prof Andreas Kulozik
Professor of Pediatric Hematology
Heidelberg University
Germany

11.05am - 11.20am

Li-Fraumeni syndrome and it’s predisposition to hematological malignancies: The Spectrum.

Dr. Reem Al Sulaiman and

Dr. Mariem Sidenna

Genetic Counselors
NCCCR, Doha - Qatar

11.20am - 11.35am

Challenging diagnostic case in ALL

Dr. Samah Kohla
Hematopathology - DLMP
HMC - Qatar

11.25am - 11.40am

Q and A Session

11.40am - 1pm

Prayer and Lunch

Session IIA: Management of ALL

Moderators: Dr. Honar Cherif, Dr. Ayman Saleh, Dr. Liam Fernyhough

1pm - 1.20pm

ALL and Obesity

Dr. Ruba Y. Taha
Hematology - BMT Dept.
NCCCR - HMC
Qatar

1.20pm - 1.40pm

Management of Philadelphia Negative ALL in children and adolescents

Prof Andreas Kulozik
Heidelberg University
Germany

1.40pm - 2.10pm

Progress in research and therapy of ALL at Md Anderson in 2023- (Hybrid presentation)

Prof. Hagop Kantarjian
Professor in University of Texas
Chair of Leukemia Department
Md Anderson Cancer Center
Huston, USA

2.10pm - 2.30 pm

Philadelphia positive-ALL: Do we still need systemic chemotherapy and allogenic HSCT?

Prof. Robin Foa
Professor of Hematology - University of Rome, Italy

2.30pm - 2.45pm

Philadelphia positive leukemia in adults in Qatar

Dr. Amna Gameil
Hematology - BMT Dept.
NCCCR - HMC
Qatar

2.45pm - 3pm

Q and A Session

3pm - 3.40pm

Poster Viewing and Presentation

Moderators: Dr. Mohd. Bakr, Dr. Firyal Ibrahim, Dr. Anil Ellahie

3.40pm - 4pm

Cancer associated thrombosis.

Dr. Hesham El Sabah
Hematology - BMT Dept.
NCCCR - HMC
Qatar

4pm - 4.20pm

Role of allogenic HSCT in ALL and future directives

Dr. Javid Gaziev
Chairman of Hematology and BMT
Director of BMT
NCCCR - HMC
Qatar

4.20pm - 4.50pm

CAR T Therapy in Relapse Refractory B-ALL and next Generation CAR T

Dr. Marco Ruella
University of Pennsylvania
USA

4.50pm - 5.05pm

Invasive fungal infections in leukemia: Role of prophylaxis

Dr. Ali Omrani
Sr. Consultant - Infection Disease
CDC, HMC - Qatar

5.05pm - 5.20pm

Palliative and quality of life in patients with leukemia

Dr. Ayman Allam
Senior Consultant - Palliative Medicine
HMC - Qatar

5.20pm - 5.35pm

Q and A Session

5.35pm

Closing Day 1